The Role of Glycosylation in Inflammatory Diseases

Adv Exp Med Biol. 2021:1325:265-283. doi: 10.1007/978-3-030-70115-4_13.

Abstract

The diversity of glycan presentation in a cell, tissue and organism is enormous, which reflects the huge amount of important biological information encoded by the glycome which has not been fully understood. A compelling body of evidence has been highlighting the fundamental role of glycans in immunity, such as in development, and in major inflammatory processes such as inflammatory bowel disease, systemic lupus erythematosus and other autoimmune disorders. Glycans play an instrumental role in the immune response, integrating the canonical circuits that regulate innate and adaptive immune responses. The relevance of glycosylation in immunity is demonstrated by the role of glycans as important danger-associated molecular patterns and pathogen-associated molecular patterns associated with the discrimination between self and non-self; also as important regulators of the threshold of T cell activation, modulating receptors signalling and the activity of both T and other immune cells. In addition, glycans are important determinants that regulate the dynamic crosstalk between the microbiome and immune response. In this chapter, the essential role of glycans in the immunopathogenesis of inflammatory disorders will be presented and its potential clinical applications (diagnosis, prognosis and therapeutics) will be highlighted.

Keywords: Glomerulonephritis; Glycosylation; IBD; Inflammatory diseases; Myositis; T-cells.

MeSH terms

  • Autoimmune Diseases*
  • Glycosylation
  • Humans
  • Lupus Erythematosus, Systemic*
  • Lymphocyte Activation
  • Polysaccharides

Substances

  • Polysaccharides